Myriad Genetics, Inc. announced that a study published in the Journal of Clinical Psychopharmacology found that the GeneSight® Psychotropic Test significantly reduced psychiatric hospitalizations in ...
A recent study of a million people with 14 psychiatric disorders showed these disorders fell into five genetic clusters.